MJN complies with NAD
This article was originally published in The Tan Sheet
Executive Summary
Mead Johnson Nutritionals says advertising for its Enfamil LIPIL infant formula currently complies with National Advertising Division recommendations, although an oversight initially made it noncompliant. Following a challenge by Abbott Nutrition and three compliance reviews, MJN continued to defy NAD's decision, leaving the self-regulatory forum "no choice but to refer this matter" to the Federal Trade Commission, NAD says Feb. 24. Abbott challenged the claim that MJN's product "is the only infant formula shown in independent clinical studies to improve baby's brain and eye development." An MJN spokeswoman says Feb. 26 the Evansville, Ind.-based firm attempted to comply with NAD's decision, despite disagreeing with aspects of it, but a single coupon with the contested claim "escaped our scrutiny and inadvertently was continued." The coupon has been discontinued, marking full compliance with NAD's decision, the spokeswoman says
You may also be interested in...
Mead Johnson Drops Triple Health Guard Formula Exclusivity Claim - NAD
Mead Johnson Nutrition modifies its advertising for Enfamil Premium With Triple Health Guard after the National Advertising Division says an exclusivity claim touting the infant formula product's superior benefits may confuse consumers
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.